Conduct Phase III CT : CDSCO panel tells AstraZeneca for anticancer drug Olaparib Film coated Tablet Dr. Divya Colin17 March 2023 12:30 PM GMTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has opined the drug major...
CDSCO Panel Tells Synokem to conduct phase 3 CT of antidiabetic FDC drug Dr. Divya Colin5 Feb 2023 12:30 PM GMTNew Delhi: Highlighting that there is no sufficient data, no unmet need & and FDC is not approved the drug internationally, the Subject Expert...
Submit adequate justification: CDSCO Panel tells Synokem pharma about Phase III CT of Naftifine Cream Dr. Divya Colin26 Oct 2022 6:15 AM GMTNew Delhi: Regarding the ongoing Phase III Clinical trial with the drug Naftifine HCI Cream 2%w/w, the Subject Expert Committee (SEC) functional under...
Synokem Pharma Gets CDSCO Panel nod to study Anti Allergic Combination Drug Dr. Divya Colin15 Oct 2022 12:30 PM GMTNew Delhi: Synokem Pharmaceutical has got a go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
IQVIA Gets CDSCO Panel Nod To Study AVT06 biosimilar candidate to Eylea Dr. Divya Colin9 Oct 2022 8:10 AM GMTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted permission to the...
JnJ gets CDSCO Panel nod to study antipsychotic drug Paliperidone Palmitate Dr. Divya Colin29 Sep 2022 12:30 PM GMTNew Delhi: Pharmaceutical major, Johnson and Johnson has got a go ahead from the Subject Expert Committee SEC functional under Central Drug Standard...
NovoNordisk Gets CDSCO Panel Nod To Study anti-diabetic FDC Cagrilinitide,Semaglutide Dr. Divya Colin19 Sep 2022 12:30 PM GMTNew Delhi: Advising to submit the trial safety and efficacy data, the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
CDSCO panel seeks justification for Pfizer Phase III CT of 20-Valent Pneumococcal Conjugate Vaccine Dr. Divya Colin11 Sep 2022 6:05 AM GMTNew Delhi: In response to the drug major Pfizer's Phase III clinical trial proposal for Pneumococcal Polysaccharide Conjugate Vaccine (20 Valent), the...
Ultra rapid lispro in basal-bolus regimen bests lispro for PPG control in type 2 diabetes Dr. Kamal Kant Kohli30 Aug 2022 3:30 AM GMTUltra rapid lispro (URLi) is a novel formulation of insulin lispro designed to more closely match the physiological insulin response to a meal, with...
Intas Pharma Gets CDSCO Panel Okay To Study Human Normal Immunoglobulin Dr. Divya Colin25 July 2022 12:30 PM GMTNew Delhi: Pharmaceutical major Intas Pharma has got the go-head from the Subject Expert Committee (SEC) functional under Central Drug Standard...
Nonhormonal vaginal gel exhibits significant contraception in Phase 3 AMPOWER Clinical Trial Dr. Kamal Kant Kohli6 July 2022 5:15 AM GMTAccording to findings from a post hoc analysis of the registrational phase 3 AMPOWER trial, use of Phexxi® (lactic acid, citric acid, potassium...
Exhalation delivery system reduces inflammation of nasal cavity and symptoms of chronic sinusitis Dr. Kamal Kant Kohli17 Jun 2022 2:00 PM GMTAn exhalation delivery system that uses fluticasone propionate nasal spray may reduce symptoms of chronic sinusitis and local inflammation of the...
